Couldn’t attend World ADC in 2011?

A video recording of last year's World ADC Summit in San Francisco is now available to purchase. For just $999, you will have online access to the presentations, question & answer sessions and panel discussions at the Summit. Listen and learn from our expert speaker panel, including Genentech, Seattle Genetics, Regeneron, Genmab and many more, from the comfort of your office.

Over 10 hours of high quality video from the only commercial meeting focussed on Antibody Drug Conjugates
Easy to use online format: Log in any time, anywhere to access the exclusive footage
Video and audio recording synced with presentation slides for an easy viewing experience

See below for a list of available presentations.

The presentations available in the ADC OnDemand package include:

Day 1 - Wednesday 26th October 2011

Chairman's Opening Remarks

Pamela Trail, Vice President, Regeneron

Mechanisms of Resistance to ADCs

Gail Lewis Philips, Scientist, Genentech

Clinical Pharmacology and Pharmacometric Considerations in the Development of ADCs

Manish Gupta, Scientist, Genentech

**Panel: Understanding in vivo ADC Properties & Metabolism – Feeding Back Knowledge into Design**

Hans Erickson, Principal Scientist, ImmunoGen
Mike Wheatcroft, Research Manager, Avipep
Jagath Junutula, Senior Scientist, Genentech

Manufacturing of ADCs to Enable Preclinical and Clinical Testing

Michael Bienkowski, Manager, Process Development, SAFC

Considerations for Effective Manufacturing of Antibody Drug Conjugates

Tom Rohrer, Senior Director, Lonza

Overcoming Challenges in ADC Finished Product

Frank Kogelberg, Manager, Contract Manufacturing, Baxter

Day 2 - Thursday 27th October 2011

Chairman's Opening Remarks

Jagath Junutula, Senior Scientist, Genentech

Optimizing ADC Efficacy Using Calicheamicin and Other Payloads

Hans Peter Gerber, Senior Director, Pfizer

Engineered Toxin Bodies (ETBs) as a New Class of Targeted Biologics

Eric Poma, CEO, Molecular Templates

Redefining PEGylation: dPEG®s and their ADC Present and Future

Paul Davis, Chief Executive Officer, Quanta BioDesign

Proteomics for the Discovery of Targetable Antigens for the Development of Antibody Drug Conjugates

Dr. Jonathan Terrett, Chief Scientific Officer, Oxford BioTherapeutics Ltd

A Guide to Target Selection, Using PSMA as an Example

Neil Bander, Professor, Weill Cornell Medical College

Panel: What Targets are Best? What is the Influence of Target Density on Tumor Surface? How Important is it that the Targets Internalize?

Neil Bander, Professor, Weill Cornell Medical College

Leonard Reyno, Chief Medical Officer, Agensys

John Lambert, Chief Scientific Officer, ImmunoGen

Panel: Comparing the Potential of Low Molecular Weight Delivery Vehicles with Classic Antibody Formats

Mike Wheatcroft, Research Manager, Avipep
Shane Olwill, Senior Director, Pieris
Neil Bander, Professor, Weill Cornell Medical College
Hans Peter Gerber, Senior Director, Pfizer

If you’d like to purchase ADC OnDemand, you can book online here.

Alternatively, please email: info@hansonwade.com or call us on +1 212 537 5898 and we will issue an invoice.

If you have any questions about ADC OnDemand, please don’t hesitate to get in touch.